-
MoonLake Immunotherapeutics (NASDAQ:MLTX) Given Average Recommendation of "Moderate Buy" by Analysts
Source: Buzz FX / 23 Nov 2024 02:46:08 America/New_York
MoonLake Immunotherapeutics (NASDAQ:MLTX) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat November 23, 2024 Share Link copied to clipboard. Shares of MoonLake Immunotherapeutics ( NASDAQ:MLTX - Get Free Repo
Read more...